Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 9/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 6/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 6/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 4/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3854699 | 0.86 | MAPK14 (0.40) | MAPK14PIK3CATGFBR1PIK3CBMTOR | |
| SCHEMBL3847367 | 0.85 | PIK3CA (0.42) | MAPK14PIK3R1PIK3CATGFBR1PIK3CD | |
| SCHEMBL3846792 | 0.84 | TGFBR1 (0.38) | MAPK14PIK3R1PIK3CATGFBR1PIK3CD | |
| SCHEMBL3849488 | 0.84 | MAPK14 (0.40) | MAPK14TGFBR1 | |
| SCHEMBL3852731 | 0.82 | PIK3CA (0.42) | MAPK14PIK3R1PIK3CATGFBR1PIK3CD | |
| SCHEMBL3847843 | 0.81 | MAPK14 (0.45) | MAPK14PIK3R1PIK3CATGFBR1PIK3CD | |
| SCHEMBL3849147 | 0.80 | MAPK14 (0.34) | MAPK14LRRK2 | |
| SCHEMBL3849288 | 0.79 | PTGS2 (0.37) | MAPK14PIK3R1PIK3CATGFBR1 | |
| SCHEMBL3846800 | 0.79 | CNR2 (0.39) | MAPK14PIK3CAPIK3CBMTOR | |
| SCHEMBL3847653 | 0.79 | KIT (0.36) | PIK3CATGFBR1PIK3CBMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |